Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD14: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD14 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, regulates. Associated with ALS, Aging, Als. Connected to 169 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | CD14 |
| Full Name | CD14 Molecule |
| Chromosome | 5q31.3 |
| Protein Type | Receptor |
| Function | Its primary roles include |
| Primary Expression | Monocytes, Macrophages, Neutrophils, Microglia |
| Molecular Weight | 40 kDa |
| Amino Acids | 382 aa |
| Pathways | Amyloid, Calcium Signaling, Hedgehog, Nf-Κb, Phagocytosis |
| UniProt ID | P08571 |
| NCBI Gene ID | 929 |
| Ensembl ID | ENSG00000144891 |
| OMIM | 158120 |
| GeneCards | CD14 |
| Human Protein Atlas | CD14 |
| Associated Diseases | Als, Alzheimer, Atherosclerosis, Carcinoma, Cardiomyopathy |
| Interactions | AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND, ANXA2 |
| KG Connections | 373 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CD14["CD14"]
CD14 -.biomarker for.-> Cancer["Cancer"]
CD14 -.biomarker for.-> Als["Als"]
CD14 -.biomarker for.-> Aging["Aging"]
CD14 -.biomarker for.-> Ms["Ms"]
CD14 -->|"interacts"| Alzheimer["Alzheimer"]
CD14 -->|"target for"| Obesity["Obesity"]
CD14 -->|"target for"| Inflammation["Inflammation"]
CD14 -->|"regulates"| Arthritis["Arthritis"]
MMP9["MMP9"] -.biomarker for.-> CD14
CMKLR1["CMKLR1"] -->|"interacts"| CD14
RAGE["RAGE"] -->|"interacts"| CD14
CD4["CD4"] -->|"target for"| CD14
ICAM1["ICAM1"] -->|"activates"| CD14
TREM2["TREM2"] -->|"activates"| CD14
TLR2["TLR2"] -->|"activates"| CD14
NFKBIA["NFKBIA"] -->|"activates"| CD14
MRC1["MRC1"] -->|"activates"| CD14
IL1B["IL1B"] -->|"activates"| CD14| Target | Relation | Type | Str |
|---|---|---|---|
| monocyte/macrophage differentiation | involved_in | process | 0.90 |
| macrophages | expressed_in | cell_type | 0.80 |
| Als | associated_with | disease | 0.75 |
| Als | causes | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Nf-Κb | activates | pathway | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| Obesity | therapeutic_target | disease | 0.65 |
| Myocardial Infarction | associated_with | disease | 0.65 |
| Psoriasis | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Schizophrenia | expressed_in | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Coronary Artery Disease | associated_with | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Carcinoma | causes | disease | 0.65 |
| Inflammation | degrades | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Infection | interacts_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Obesity | inhibits | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Obesity | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Senescence | regulates | disease | 0.65 |
| Infection | regulates | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Hepatocellular Carcinoma | causes | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Arthritis | regulates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TREM2 | activates | gene | 0.70 |
| TLR2 | activates | gene | 0.60 |
| NFKBIA | activates | gene | 0.60 |
| MRC1 | activates | gene | 0.60 |
| IL1B | activates | gene | 0.60 |
| ITGAM | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| CXCL2 | activates | gene | 0.60 |
| ANXA2 | activates | gene | 0.60 |
| CD44 | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| SPP1 | activates | gene | 0.60 |
| TIMP1 | activates | gene | 0.60 |
| LGALS3 | activates | gene | 0.60 |
| CD8 | associated_with | gene | 0.60 |
| CXCL10 | associated_with | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| NRP1 | associated_with | gene | 0.60 |
| INFLAMMATION | degrades | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| NF-ΚB | regulates | gene | 0.60 |
| ROS | regulates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| MRPS31 | associated_with | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| INOS | activates | gene | 0.60 |
| FOXP3 | activates | gene | 0.60 |
| RORC | associated_with | gene | 0.60 |
| CD4 | associated_with | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| TLR4 | regulates | gene | 0.60 |
| MYD88 | regulates | gene | 0.60 |
| TIRAP | activates | gene | 0.60 |
| DOT1L | regulates | gene | 0.60 |
| PIEZO1 | regulates | gene | 0.60 |
| TIMMDC1 | therapeutic_target | gene | 0.60 |
| BCS1L | associated_with | gene | 0.60 |
| APOC1 | activates | gene | 0.60 |
| C1QA | activates | gene | 0.60 |
| C1QC | activates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| CD163 | degrades | gene | 0.60 |
| MMP2 | biomarker_for | gene | 0.60 |
| RORC | therapeutic_target | gene | 0.60 |
| GPR109A | activates | gene | 0.60 |
| P53 | activates | gene | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 5 hypotheses Top: 0.720
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning CD14 in their description or question text
No additional research found